Bob T. Li

Also affiliated with NewYork–Presbyterian Hospital, Cornell University, New York Hospital Queens, Presbyterian Hospital, AstraZeneca (United States), Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

Nature Communications(2023)10.1038/s41467-023-40793-x

Top 16%

1.3DataRank

Top 16%63 citations

Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan +12 more

Papers

Driven by 50 papers — median percentile 84. Top paper: “Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial”.

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00064-0

N/A

3.7DataRank · unranked

164 citations

Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares +15 more

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Journal of Clinical Oncology(2024)10.1200/jco.23.01308

N/A

1.9DataRank · unranked

94 citations

Eric J. Sherman, Heiko Schöder, Rick Wray, Jay O. Boyle, Bhuvanesh Singh +37 more

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

Nature Communications(2023)10.1038/s41467-023-40793-x

Top 16%

1.3DataRank

Top 16%63 citations

Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan +12 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009

N/A

0.998DataRank · unranked

19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Diverse alterations associated with resistance to KRAS(G12C) inhibition

Nature(2021)10.1038/s41586-021-04065-2

N/A

0.919DataRank · unranked

458 citations

Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai +23 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0.854DataRank · unranked

295 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0.782DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0.744DataRank · unranked

142 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2278

N/A

0.724DataRank · unranked

124 citations

Melissa L. Johnson, Sarah Clifford, Romel Somwar, Jennifer Kherani, Jieun Son +23 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0.723DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0423

N/A

0.700DataRank · unranked

105 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Genomic mapping of metastatic organotropism in lung adenocarcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.018

N/A

0.681DataRank · unranked

93 citations

Brooke Mastrogiacomo, James G. Connolly, Kay See Tan, Yuan Liu, Cameron N. Fick +22 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0.614DataRank · unranked

59 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Modeling lung adenocarcinoma metastases using patient-derived organoids

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101777

N/A

0.470DataRank · unranked

22 citations

Manendra B. Lankadasari, Joel Rosiene, Kofi E. Johnson, Juan Zhou, Samhita Bapat +23 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0.457DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers

The Oncologist(2023)10.1093/oncolo/oyad247

N/A

0.396DataRank · unranked

13 citations

Ann Maria, Nicolas Toumbacaris, HuiYong Zhao, Katherine E. Kargus, Morgan Bryant +11 more

Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study

JCO Precision Oncology(2021)10.1200/po.20.00184

N/A

0.365DataRank · unranked

5 citations

Jonathan Reichel, Jiabin Tang, Juber Patel, Fanli Meng, Duygu Selcuklu +15 more

Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100607

N/A

0.345DataRank · unranked

9 citations

Ryka Sehgal, Rachel Saganty, Anne S. Reiner, Ahmet Turan Ilıca, Emily Miao +8 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.056

N/A

0.345DataRank · unranked

9 citations

Junting Zheng, Kay See Tan, Corinne C. Liu, Bernard J. Park, Gaetano Rocco +12 more

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer

JCO Precision Oncology(2024)10.1200/po.24.00216

N/A

0.345DataRank · unranked

9 citations

Angela BY Hui, José de Arimateia Batista Araújo-Filho, Emily G. Hamilton, Jacob J. Chabon, Everett J. Moding +20 more

Clinical and genomic characterization of ERBB2-altered gallbladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4114

N/A

0.334DataRank · unranked

4 citations

Nikolaus Schultz, Juan Carlos Roa, Henry Walch, Santiago A. Sepúlveda, James J. Harding +7 more

Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21098

N/A

0.330DataRank · unranked

8 citations

Debra A. Goldman, Sabrina T. Lin, Darren J. Buonocore, Jianjiong Gao, Jason C. Chang +15 more

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

Lung Cancer(2023)10.1016/j.lungcan.2023.02.005

N/A

0.330DataRank · unranked

8 citations

Jordan Eichholz, Emily S. Lebow, Jessica Flynn, Zhigang Zhang, Henry Walch +14 more

Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort

JCO Global Oncology(2024)10.1200/go.24.00090

N/A

0.281DataRank · unranked

4 citations

Henry Walch, Santiago A. Sepúlveda, Nikolaus Schultz, Gonzalo Muñoz, Amin Yaqubie +11 more

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

European Journal of Cancer(2024)10.1016/j.ejca.2024.114257

N/A

0.269DataRank · unranked

5 citations

Tatiana Erazo, Justin Jee, Andrea Arfè, Avantika Gupta, Luke Pike +28 more

Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9067

N/A

0.269DataRank · unranked

5 citations

Angela B. Hui, Jacob J. Chabon, Everett J. Moding, Emily S. Lebow, José de Arimateia Batista Araújo-Filho +15 more

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.09.009

N/A

0.104DataRank · unranked

1 citations

Leena Gandhi, Vignesh Ravichandran, Benjamin Besse, Julien Mazières, Geoffrey I. Shapiro +20 more

Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post–Hospital Discharge

JCO Clinical Cancer Informatics(2024)10.1200/cci-24-00182

N/A

0.104DataRank · unranked

1 citations

Sahil D. Doshi, Ann M. Mazzella Ebstein, Jessie C. Holland, Ayelet Sapir, Michael Leung +12 more

Lung resection after initial nonoperative treatment for non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.11.040

N/A

0DataRank · unranked

13 citations

Cameron N. Fick, Kay See Tan, Nicolas Toumbacaris, Brooke Mastrogiacomo, Prasad S. Adusumilli +15 more

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1014

N/A

0DataRank · unranked

356 citations

Hiroji Iwata, Ian E. Krop, Pasi A. Jänne, Toshihiko Doi, Shunji Takahashi +11 more

Characterization of on-target adverse events caused by TRK inhibitor therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.05.006

N/A

0DataRank · unranked

86 citations

James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff +16 more

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.09.009

N/A

0DataRank · unranked

27 citations

Navin K. Chintala, Raj G. Vaghjiani, Rachel Grosser, Kay See Tan, Xiaoyu Li +14 more

Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy

Ophthalmology Retina(2021)10.1016/j.oret.2021.06.001

N/A

0DataRank · unranked

14 citations

Julia Canestraro, Dianna Haggag-Lindgren, James J. Harding, Eli L. Diamond, Alexander Drilon +5 more

The emerging role of local therapy in oligometastatic non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2021)10.1016/j.jtcvs.2021.04.090

N/A

0DataRank · unranked

12 citations

Bob T. Li, Daniel R. Gomez, James M. Isbell

Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies

Journal of Molecular Diagnostics(2021)10.1016/j.jmoldx.2021.11.006

N/A

0DataRank · unranked

2 citations

Sanjay Tyagi, Salvatore A. E. Marras, Patricia Moerzinger, Juan Andrés Abin‐Carriquiry, Mauricio Cuello +9 more

Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102378

N/A

0DataRank · unranked

170 citations

Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai +9 more

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

Nature Medicine(2022)10.1038/s41591-022-01775-6

N/A

0DataRank · unranked

52 citations

Bobby Daly, Mary Gospodarowicz, Monica M. Bertagnolli, Otis W. Brawley, Bruce A. Chabner +29 more

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

Translational Lung Cancer Research(2022)10.21037/tlcr-22-164

N/A

0DataRank · unranked

7 citations

Michael Offin, Jessica Flynn, Zhigang Zhang, Emily S. Lebow, Khaled Aziz +9 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1253629

N/A

0DataRank · unranked

18 citations

Narek Shaverdian, Jordan Eichholz, L.B. Kratochvil, Megan McCune, Yonina R. Murciano‐Goroff +27 more

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0187

N/A

0DataRank · unranked

493 citations

Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato +24 more

A tailored approach to horizon scanning for cancer medicines

Journal of Cancer Policy(2023)10.1016/j.jcpo.2023.100441

N/A

0DataRank · unranked

4 citations

Yat Hang To, Marliese Alexander, Karen Trapani, Paolo A. Ascierto, Sophy Athan +28 more

Data from Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

(2023)10.1158/1078-0432.c.6530487.v1

N/A

0DataRank · unranked

0 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Large-scale clinicogenomic models of solid tumor CNS metastasis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2037

N/A

0DataRank · unranked

0 citations

Anisha Luthra, Christopher J. Fong, Karl Pichotta, Thinh Ngoc Tran, Mirella L. Altoé +15 more

Targeting KRAS in cancer

Nature Medicine(2024)10.1038/s41591-024-02903-0

N/A

0DataRank · unranked

287 citations

Bob T. Li, Eileen M. O’Reilly, Anupriya Singhal

EGFR-directed antibodies promote HER2 ADC internalization and efficacy

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101792

N/A

0DataRank · unranked

31 citations

Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z. Drago, Dazhi Liu +12 more

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0620

N/A

0DataRank · unranked

8 citations

Justin Jee, Alexander Drilon, Andreas M. Heilmann, Justin M. Allen, Alexa B. Schrock +3 more

Bob T. Li

Indexed papers

Top data-sharing exemplar

Papers